Skip to main content
PHARMARESEARCH BIO Co., Ltd. logo

PHARMARESEARCH BIO Co., Ltd. — Investor Relations & Filings

Ticker · 217950 ISIN · KR7217950005 KO Manufacturing
Open in API
Filings indexed 161 across all filing types
Latest filing 2026-03-27 Board/Management Inform…
Country KR South Korea
Listing KO 217950

About PHARMARESEARCH BIO Co., Ltd.

http://www.pr-bio.co.kr/eng/

PHARMARESEARCH BIO Co., Ltd. is a biopharmaceutical company specializing in regenerative medicine. The company leverages marine biotechnology to research, develop, and produce innovative biological products aimed at enhancing human health. Its core activities center on the development of raw materials for cell and tissue regeneration, such as Polydeoxyribonucleotide (PDRN) and Polynucleotide (PN) derived from salmon DNA. The company's research and development pipeline also includes other biological products, such as toxin-based therapeutics, to address various medical and aesthetic needs.

Recent filings

Filing Released Lang Actions
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal regulatory notice submitted to the Financial Services Commission/KRX regarding the appointment, dismissal, or mid-term resignation of outside directors (사외이사). It details names, appointment dates, terms, and professional backgrounds of new outside directors. This falls squarely under announcements of changes in the company’s board of directors or senior management. Therefore, it matches the Board/Management Information category (MANG).
2026-03-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is the official results of the company’s regular (annual) shareholders’ meeting held on 27 March 2026. It details each agenda item (approval of financial statements, amendments to the articles, director appointments, remuneration limits, etc.), shows vote counts and percentages for each resolution, and lists the record date for voting rights. This matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-03-27 Korean
사업보고서 (2025.12)
Annual Report Classification · 1% confidence The document is a 'Business Report' (사업보고서) for PharmaResearch Bio, covering the fiscal year 2025. It contains detailed company information, management discussion, financial data, and operational details. In the South Korean regulatory context, the 'Business Report' (사업보고서) is the equivalent of the annual 10-K filing, as it provides comprehensive annual financial and operational disclosures to the Financial Supervisory Service (FSS) and the Korea Exchange (KRX). FY 2025
2026-03-19 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal regulatory filing titled '감사보고서 제출' (Submission of Audit Report). It provides the audit opinion, key financial data, and auditor information for the fiscal year 2025. While it contains financial data, it is specifically a notification of the submission of the audit report to the regulatory body, which fits the definition of an Audit Report/Information (AR) filing. FY 2025
2026-03-16 Korean
주주총회집중일개최사유신고
Regulatory Filings Classification · 1% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company scheduled its AGM on a date that conflicts with the 'Shareholder Meeting Dispersion Voluntary Compliance Program'. Since this is a regulatory disclosure regarding meeting logistics and compliance rather than the meeting materials themselves or the results, it falls under the general regulatory filing category.
2026-03-12 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains detailed information about the meeting agenda, director candidates, financial statements, and voting procedures. This falls under the category of Proxy Solicitation & Information Statement.
2026-03-12 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.